Cited by 3,027Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment ResearchDeep Brain Stimulation and Movement Disorders

The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.

Clinical diagnostic criteria for dementia associated with Parkinson’s disease

Open access

Emre, Murat, Aarsland, Dag, Brown, Richard, Burn, David J., Duyckaerts, Charles, Mizuno, Yoshikino, Broe, Gerald Anthony, Cummings, Jeffrey, Dickson, Dennis W., Gauthier, Serge, Goldman, Jennifer, Goetz, Christopher, Korczyn, Amos, Lees, Andrew, Levy, Richard, Litvan, Irene, McKeith, Ian, Olanow, Warren, Poewe, Werner, Quinn, Niall, Sampaio, Christina, Tolosa, Eduardo, Dubois, Bruno·2007·Movement Disorders

DOI 10.1002/mds.21507

Open this paper in CoChat — free account

Abstract

Dementia has been increasingly more recognized to be a common feature in patients with Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of dementia associated with PD (PD‐D), however, have been lacking. A Task Force, organized by the Movement Disorder Study, was charged with the development of clinical diagnostic criteria for PD‐D. The Task Force members were assigned to sub‐committees and performed a systematic review of the literature, based on pre‐defined selection criteria, in order to identify the epidemiological, clinical, auxillary, and pathological features of PD‐D. Clinical diagnostic criteria were then developed based on these findings and group consensus. The incidence of dementia in PD is increased up to six times, point‐prevelance is close to 30%, older age and akinetic‐rigid form are associated with higher risk. PD‐D is characterized by impairment in attention, memory, executive and visuo‐spatial functions, behavioral symptoms such as affective changes, hallucinations, and apathy are frequent. There are no specific ancillary investigations for the diagnosis; the main pathological correlate is Lewy body‐type degeneration in cerebral cortex and limbic structures. Based on the characteristic features associated with this condition, clinical diagnostic criteria for probable and possible PD‐D are proposed. © 2007 Movement Disorder Society

Integrity signals

Registry

Crossref · 10.1002/mds.21507

Cites

188 of 188 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Self-citation
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citation
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., ZACCAI, J. H., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,714
Self-citation
Prevalence and Characteristics of Dementia in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403
Self-citation
Rivastigmine for Dementia Associated with Parkinson's Disease
Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., Deyn, P. P. D., Durif, F., Kulisevsky, J., van Laar, T., Lees, A. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041470 · Cited by 1,219
Self-citation
Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years
Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fénelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,035

Show all 187 references

Research works printed but not linked: 3

McKeith IG, 2000, Neurologic clinics, 865
10.1136/jnnp.2003.033530 · DOI
10.1002/1099-1166(200102)16:2<184::AID-GPS304>3.0.CO;2-K · DOI

Sorted by citations

Items 401–500 of 1,006

Identification of Glutathione S-Transferase Pi as a Protein Involved in Parkinson Disease Progression
Shi, M. Y., Bradner, J. M., Bammler, T. K., Eaton, D. L., Zhang, J., Ye, Z., Wilson, A. M., Montine, T. J., Pan, C., & Zhang, J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081019 · Cited by 85
Volumetric analysis of the substantia innominata in patients with Parkinson's disease according to cognitive status
Choi, S. H., Jung, T.-M., Lee, J. E., Lee, S., Sohn, Y. H., & Lee, P. H. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.11.015 · Cited by 83
Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation
Williams, A. E., Arzola, G. M., Strutt, A. M., Simpson, R. K., Jankovic, J. J., & York, M. K. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.01.011 · Cited by 85
Quantitative electroencephalography as a marker of cognitive fluctuations in dementia with Lewy bodies and an aid to differential diagnosis
Stylianou, M., Murphy, N., Peraza, L. R., Graziadio, S., Cromarty, R., Killen, A., O' Brien, J. T., Thomas, A. J., LeBeau, F. E. N., & Taylor, J.-P. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.03.013 · Cited by 79
Cognitive impairment and dementia in Parkinson's disease: Practical issues and management
Emre, M., Ford, P. J., Bılgıç, B., & Uc, E. Y. (2014) · Movement Disorders · doi:10.1002/mds.25870 · Cited by 84
Self-citation
Cognition in Parkinson's Disease
O’Callaghan, C., & Lewis, S. J. G. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.002 · Cited by 90
Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia
Llorens, F., Schmitz, M., Karch, A., Cramm, M., Lange, P., Gherib, K., Varges, D., Schmidt, C., Zerr, I., & Stoeck, K. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.10.009 · Cited by 84
The organization of narrative discourse in Lewy body spectrum disorder
Ash, S., McMillan, C. T., Gross, R. G., Cook, P. A., Morgan, B. E., Boller, A., Dreyfuss, M., Siderowf, A. D., & Grossman, M. (2011) · Brain and Language · doi:10.1016/j.bandl.2011.05.006 · Cited by 92
Improving functional disability and cognition in Parkinson disease
Peña, J., Ibarretxe‐Bilbao, N., García‐Gorostiaga, I., Gómez‐Beldarrain, M. Á., Díez‐Cirarda, M., & Ojeda, N. (2014) · Neurology · doi:10.1212/wnl.0000000000001043 · Cited by 83
Approach to Cognitive Impairment in Parkinson's Disease
Zhang, Q., Aldridge, G. M., Narayanan, N., Anderson, S. W., & Uc, E. Y. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00963-x · Cited by 87
Flexible brain dynamics underpins complex behaviours as observed in Parkinson’s disease
Sorrentino, P., Rucco, R., Baselice, F., Micco, R. D., Tessitore, A., Hillebrand, A., Mandolesi, L., Breakspear, M. J., Gollo, L. L., & Sorrentino, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-83425-4 · Cited by 84
Lewy body disease or diseases with Lewy bodies?
Menšíková, K., Matěj, R., Colosimo, C., Rosales, R. L., Tučková, L., Ehrmann, J., Hraboš, D., Kolaříková, K., Vodička, R., Vrtěl, R., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-021-00273-9 · Cited by 96
Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson's disease
Shin, S., Lee, J. E., Hong, J. Y., Sunwoo, M.-K., Sohn, Y. H., & Lee, P. H. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303391 · Cited by 83
Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
Horne, K., Myall, D. J., Livingston, L., Melzer, T. R., Pitcher, T. L., MacAskill, M. R., Geurtsen, G. J., Anderson, T., & Dalrymple‐Alford, J. C. (2016) · npj Parkinson s Disease · doi:10.1038/npjparkd.2015.27 · Cited by 83
Dental care utilization in patients with different types of dementia: a longitudinal nationwide study of 58,037 individuals
Fereshtehnejad, S., Garcia‐Ptacek, S., Religa, D., Holmer, J., Buhlin, K., Eriksdotter, M., & Sandborgh‐Englund, G. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.05.004 · Cited by 81
Cognitive signature of brain FDG PET based on deep learning: domain transfer from Alzheimer’s disease to Parkinson’s disease
Initiative, A. D. N., Choi, H., Kim, Y. K., Yoon, E. J., Lee, J., & Lee, D. S. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04538-7 · Cited by 82
Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
Dewan, R., Chia, R., Ding, J., Hickman, R. A., Stein, T. D., Abramzon, Y. A., Ahmed, S., Sabir, M. S., Portley, M. K., Tucci, A., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.11.005 · Cited by 95
Self-citation
Nonmotor Manifestations in Parkinson Disease
Bernal-Pacheco, Ó., Limotai, N., Go, C. L., & Fernandez, H. H. (2012) · The Neurologist · doi:10.1097/nrl.0b013e31823d7abb · Cited by 84
8-OHdG in Cerebrospinal Fluid as a Marker of Oxidative Stress in Various Neurodegenerative Diseases
Gmitterová, K., Heinemann, U., Gawinecka, J., Varges, D., Ciesielczyk, B., Valkovič, P., Benetin, J., & Zerr, I. (2009) · Neurodegenerative Diseases · doi:10.1159/000237221 · Cited by 83
[11C]PIB-, [18F]FDG-PET and MRI imaging in patients with Parkinson’s disease with and without dementia
Jokinen, P., Scheinin, N. M., Aalto, S., Någren, K., Savisto, N., Parkkola, R. K., Rokka, J., Haaparanta‐Solin, M., Röyttä, M., & Rinne, J. O. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.08.021 · Cited by 82
Dementia with Lewy Bodies versus Alzheimer's Disease and Parkinson's Disease Dementia: A Comparison of Cognitive Profiles
Park, K. W., Kim, H. S., Cheon, S., Cha, J., Kim, S., & Kim, J. W. (2011) · Journal of Clinical Neurology · doi:10.3988/jcn.2011.7.1.19 · Cited by 84
The influence of motor and cognitive impairment upon visually-guided saccades in Parkinson's disease
MacAskill, M. R., Graham, C., Pitcher, T. L., Myall, D. J., Livingston, L., van Stockum, S., Dalrymple‐Alford, J. C., & Anderson, T. (2012) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2012.09.025 · Cited by 82
Cognitive decline in Parkinson’s disease: the impact of the motor phenotype on cognition
Wojtala, J., Heber, I. A., Neuser, P., Heller, J., Kalbe, E., Rehberg, S., Storch, A., Linse, K., Schneider, C. B., Gräber, S., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-319008 · Cited by 89
APOE , MAPT , and COMT and Parkinson’s Disease Susceptibility and Cognitive Symptom Progression
Paul, K. C., Rausch, R., Creek, M. M., Sinsheimer, J. S., Bronstein, J. M., Bordelon, Y. M., & Ritz, B. R. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-150762 · Cited by 79
Altered Microstructure in Corticospinal Tract in Idiopathic Normal Pressure Hydrocephalus: Comparison with Alzheimer Disease and Parkinson Disease with Dementia
Hattori, T., Yuasa, T., Aoki, S., Sato, R., Sawaura, H., Mori, T., & Mizusawa, H. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2570 · Cited by 81
Grey Matter Changes in Cognitively Impaired Parkinson's Disease Patients
Rektorová, I., Biundo, R., Mareček, R., Weis, L., Aarsland, D., & Antonini, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085595 · Cited by 81
Self-citation
Advances in the treatment of cognitive impairment in P arkinson's disease
Goldman, J. G., & Weintraub, D. A. (2015) · Movement Disorders · doi:10.1002/mds.26352 · Cited by 80
Self-citation
Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
Melzer, T. R., Stark, M. R., Keenan, R. J., Myall, D. J., MacAskill, M. R., Pitcher, T. L., Livingston, L., Grenfell, S., Horne, K., Young, B., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00391 · Cited by 79
Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug‐Naive Parkinson's Disease
Wilson, H., Pagano, G., de Natale, E. R., Mansur, A., Caminiti, S. P., Polychronis, S., Middleton, L. T., Price, G., Schmidt, K. F., Gunn, R. N., et al. (2020) · Movement Disorders · doi:10.1002/mds.28064 · Cited by 82
Clinicopathological Outcomes of Prospectively Followed Normal Elderly Brain Bank Volunteers
Dugger, B. N., Hentz, J. G., Adler, C. H., Sabbagh, M. N., Shill, H. A., Jacobson, S. A., Caviness, J. N., Belden, C. M., Driver‐Dunckley, E. D., Davis, K. J., et al. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000046 · Cited by 83
Clock Drawing in the Montreal Cognitive Assessment: Recommendations for Dementia Assessment
Price, C. C., Cunningham, H., Coronado, N., Freedland, A., Cosentino, S., Penney, D. L., Pennisi, A., Bowers, D., Okun, M. S., & Libon, D. J. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000324639 · Cited by 80
What Can Quantitative Gait Analysis Tell Us about Dementia and Its Subtypes? A Structured Review
Ardle, R. M., Morris, R., Wilson, J., Galna, B., Thomas, A. J., & Rochester, L. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170541 · Cited by 82
Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
Gaig, C., Vilas, D., Infante, J., Sierra, M., García‐Gorostiaga, I., Buongiorno, M., Ezquerra, M., Martı́, M. J., Valldeoriola, F., Aguilar, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108982 · Cited by 79
Self-citation
Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies
Smirnov, D. S., Galasko, D. R., Edland, S. D., Filoteo, J. V., Hansen, L. A., & Salmon, D. P. (2020) · Neurology · doi:10.1212/wnl.0000000000009434 · Cited by 80
Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease
Filippi, M., Canu, E., Donzuso, G., Stojković, T., Basaia, S., Stanković, I., Tomić, A., Marković, V., Petrović, I. N., Stefanova, E. D., et al. (2020) · Movement Disorders · doi:10.1002/mds.28228 · Cited by 79
Neuropsychological correlates of theory of mind in patients with early Parkinson's disease
Santangelo, G., Vitale, C., Trojano, L., Errico, D., Amboni, M., Barbarulo, A. M., Grossi, D., & Barone, P. (2011) · Movement Disorders · doi:10.1002/mds.23949 · Cited by 83
Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson's Disease
Connolly, B. S., & Fox, S. H. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0238-x · Cited by 78
Design of a comprehensive Alzheimer's disease clinic and research center in Spain to meet critical patient and family needs
Boada, M., Tárraga, L., Hernández, I., Valero, S., Alegret, M., Ruiz, A., López, O. L., & Becker, J. T. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.03.006 · Cited by 79
Slowing of EEG Background Activity in Parkinson’s and Alzheimer’s Disease with Early Cognitive Dysfunction
Benz, N., Hatz, F., Bousleiman, H., Ehrensperger, M. M., Gschwandtner, U., Hardmeier, M., Rüegg, S. J., Schindler, C., Zimmermann, R., Monsch, A. U., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00314 · Cited by 81
Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson’s disease
Teo, K. C., & Ho, S. (2013) · Translational Neurodegeneration · doi:10.1186/2047-9158-2-19 · Cited by 79
Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson’s disease: A meta-analysis
Xie, Y., Feng, H., Peng, S., Xiao, J., & Zhang, J. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.11.007 · Cited by 79
Regional Overlap of Pathologies in Lewy Body Disorders
Colom‐Cadena, M., Grau‐Rivera, O., Planellás, L., Cerquera‐Cleves, C., Morenas‐Rodríguez, E., Helgueta, S., Muñoz, L., Kulisevsky, J., Martı́, M. J., Tolosa, E. S., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx002 · Cited by 80
Self-citation
Cognitive impairment in Parkinson's disease
Cosgrove, J., Alty, J., & Jamieson, S. (2015) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2015-133247 · Cited by 78
Normative Data of the Montreal Cognitive Assessment in the Greek Population and Parkinsonian Dementia
Konstantopoulos, K., Vogazianos, P., & Doskas, T. K. (2016) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acw002 · Cited by 78
GBA Variants in Parkinson's Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes
Greuel, A., Trezzi, J., Glaab, E., Ruppert, M. C., Maier, F., Jäger, C., Hodak, Z., Lohmann, K., Ma, Y., Eidelberg, D., et al. (2020) · Movement Disorders · doi:10.1002/mds.28225 · Cited by 79
Neuropathology of Lewy body disorders
Kövari, E., Horvath, J. E., & Bouras, C. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.06.018 · Cited by 78
The Role of Vitamin D in Disease Progression in Early Parkinson’s Disease
Sleeman, I. J., Aspray, T., Lawson, R. A., Coleman, S. Y., Duncan, G. W., Khoo, T. K., Schoenmakers, I., Rochester, L., Burn, D. J., & Yarnall, A. J. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171122 · Cited by 78
Self-citation
Diffusion alterations associated with Parkinson's disease symptomatology: A review of the literature
Hall, J. M., Martens, K. A. E., Walton, C. C., O’Callaghan, C., Keller, P. E., Lewis, S. J. G., & Moustafa, A. A. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.09.026 · Cited by 79
The Ubiquitin System in Alzheimer’s Disease
Harris, L. D., Jasem, S., & Licchesi, J. D. F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_8 · Cited by 79
Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis
Yoo, D., Bang, J.-I., Ahn, C., Nyaga, V. N., Kim, Y., Kang, M. J., & Ahn, T. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.10.007 · Cited by 81
Mattis Dementia Rating Scale 2
Matteau, E., Dupré, N., Langlois, M., Jean, L., Thivierge, S. C., Provencher, P., & Simard, M. (2011) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317511412046 · Cited by 75
Validación de la versión española del test Addenbrooke's Cognitive Examination III para el diagnóstico de demencia
Matías‐Guiu, J. A., de Bobadilla, R. F., Escudero, G., Pérez‐Pérez, J., Cortés, A., Morenas‐Rodríguez, E., Valles‐Salgado, M., Moreno‐Ramos, T., Kulisevsky, J., & Matías‐Guiu, J. (2014) · Neurología · doi:10.1016/j.nrl.2014.05.004 · Cited by 77
Body-Mass Index and Mortality in Incident Dementia: A Cohort Study on 11,398 Patients From SveDem, the Swedish Dementia Registry
Ptacek, S. G., Kåreholt, I., Farahmand, B. Y., Cuadrado, M. L., Religa, D., & Eriksdotter, M. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.03.001 · Cited by 79
Action verb comprehension in amyotrophic lateral sclerosis and Parkinson’s disease
York, C., Olm, C. A., Boller, A., McCluskey, L. F., Elman, L. B., Haley, J., Seltzer, E., Chahine, L. M., Woo, J. H., Rascovsky, K., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7314-y · Cited by 76
Detecting frontotemporal dementia syndromes using MRI biomarkers
Bruun, M., Koikkalainen, J. R., Rhodius‐Meester, H. F. M., Baroni, M., Gjerum, L., van Gils, M., Soininen, H. S., Remes, A. M., Hartikainen, P. H., Waldemar, G., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101711 · Cited by 78
Medical decision‐making capacity in cognitively impaired Parkinson's disease patients without dementia
Martin, R. C., Okonkwo, O. C., Hill, J., Griffith, H. R., Triebel, K. L., Bartolucci, A. A., Nicholas, A. P., Watts, R. L., Stover, N. P., Harrell, L. E., et al. (2008) · Movement Disorders · doi:10.1002/mds.22170 · Cited by 75
Cerebral white matter hyperintensity in Parkinson's disease: A major risk factor for mild cognitive impairment
Kandiah, N., Mak, E., Ng, A., Huang, S., Au, W. L., Sitoh, Y. Y., & Tan, L. C. S. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.03.008 · Cited by 75
Improving memory in Parkinson's disease: A healthy brain ageing cognitive training program
Naismith, S. L., Mowszowski, L., Diamond, K., & Lewis, S. J. G. (2013) · Movement Disorders · doi:10.1002/mds.25457 · Cited by 75
Human behavioral assessments in current research of Parkinson’s disease
Asakawa, T., Fang, H., Sugiyama, K., Nozaki, T., Kobayashi, S. S., Hong, Z., Suzuki, K., Mori, N., Yang, Y., Hua, F., et al. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.036 · Cited by 75
Parkinson's Disease Dementia and Lewy Body Disease
Sezgi̇n, M., Bılgıç, B., Tinaz, S., & Emre, M. (2019) · Seminars in Neurology · doi:10.1055/s-0039-1678579 · Cited by 79
Self-citation
Brain atrophy progression in Parkinson’s disease is shaped by connectivity and local vulnerability
Tremblay, C., Rahayel, S., Vo, A., Morys, F., Shafiei, G., Abbasi, N., Markello, R. D., Gan‐Or, Z., Mišić, B., & Dagher, A. (2021) · Brain Communications · doi:10.1093/braincomms/fcab269 · Cited by 70
Significance of Brain Lesions in Parkinson Disease Dementia and Lewy Body Dementia
Jellinger, K. A. (2009) · Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences · doi:10.1159/000197890 · Cited by 74
Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease
Al–Bachari, S., Parkes, L. M., Vidyasagar, R., Hanby, M. F., Tharaken, V., Leroi, I., & Emsley, H. C. A. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.07.014 · Cited by 72
Comparison of Quantitative EEGs Between Parkinson Disease and Age-Adjusted Normal Controls
Serizawa, K., Kamei, S., Morita, A., Hara, M., Mizutani, T., Yoshihashi, H., Yamaguchi, M., Takeshita, J., & Hirayanagi, K. (2008) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0b013e31818f50de · Cited by 74
Long-term duodenal levodopa infusion in Parkinson’s disease: a 3-year motor and cognitive follow-up study
Zibetti, M., Merola, A., Ricchi, V., Marchisio, A., Artusi, C. A., Rizzi, L., Montanaro, E., Reggio, D., Angelis, C., Rizzone, M. G., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6597-0 · Cited by 74
Ventricular enlargement and mild cognitive impairment in early Parkinson's disease
Dalaker, T. O., Zivadinov, R., Ramasamy, D. P., Beyer, M. K., Alves, G. W., Brønnick, K., Tysnes, O., Aarsland, D., & Larsen, J. O. (2010) · Movement Disorders · doi:10.1002/mds.23443 · Cited by 73
Self-citation
Neuropsychiatric Symptoms in Parkinson's Disease with Mild Cognitive Impairment and Dementia
Leroi, I., Pantula, H., McDonald, K. R., & Harbishettar, V. (2012) · Parkinson s Disease · doi:10.1155/2012/308097 · Cited by 81
Comparing Cerebral Perfusion in Alzheimer's Disease and Parkinson's Disease Dementia: An ASL-MRI Study
Heron, C. J. L., Wright, S. L., Melzer, T. R., Myall, D. J., MacAskill, M. R., Livingston, L., Keenan, R. J., Watts, R., Dalrymple‐Alford, J. C., & Anderson, T. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.40 · Cited by 74
Early Onset Dementia
Picard, C., Pasquier, F., Martinaud, O., Hannequin, D., & Godefroy, O. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3182056be7 · Cited by 74
18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
Smith, R. A., Schöll, M., Londos, E., Ohlsson, T. G., & Hansson, O. (2018) · Scientific Reports · doi:10.1038/s41598-018-23041-x · Cited by 76
Neuroimaging in Parkinson’s disease dementia: connecting the dots
Weil, R. S., Hsu, J. K., Darby, R. R., Soussand, L., & Fox, M. D. (2019) · Brain Communications · doi:10.1093/braincomms/fcz006 · Cited by 71
Gut Microbiota-Derived Metabolite Trimethylamine N-Oxide as a Biomarker in Early Parkinson’s Disease
Chung, S. J., Rim, J. H., Ji, D., Lee, S., Yoo, H. S., Jung, J. H., Baik, K., Choi, Y., Ye, B. S., Sohn, Y. H., et al. (2021) · Nutrition · doi:10.1016/j.nut.2020.111090 · Cited by 74
Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease
Roalf, D. R., Moore, T. M., Wolk, D. A., Arnold, S. E., Mechanic-Hamilton, D. J., Rick, J. H., Kabadi, S., Ruparel, K., Chen‐Plotkin, A. S., Chahine, L. M., et al. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-312723 · Cited by 74
Dysfunction of the Default Mode Network in Drug-Naïve Parkinson’s Disease with Mild Cognitive Impairments: A Resting-State fMRI Study
Hou, Y., Yang, J., Luo, C., Song, W., Ou, R., Liu, W., Gong, Q., & Shang, H. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00247 · Cited by 73
Plasma YKL-40 in the spectrum of neurodegenerative dementia
Villar‐Piqué, A., Schmitz, M., Hermann, P., Goebel, S., Bunck, T., Varges, D., Ferrer, I., Riggert, J., Llorens, F., & Zerr, I. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1531-3 · Cited by 75
Changes in Motor, Cognitive, and Behavioral Symptoms in Parkinson's Disease and Mild Cognitive Impairment During the COVID-19 Lockdown
Baschi, R., Luca, A., Nicoletti, A. S. Q., Caccamo, M., Cicero, C. E., D’Agate, C., Giorgi, L. D., Bianca, G. L., Castro, T. L., Zappia, M., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.590134 · Cited by 73
Regional vulnerability of hippocampal subfields and memory deficits in Parkinson's disease
Pereira, J. B., Junqué, C., Bartrés‐Faz, D., Ramírez‐Ruiz, B., Martı́, M. J., & TOLOSA, E. S. (2013) · Hippocampus · doi:10.1002/hipo.22131 · Cited by 77
Self-citation
White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease
Dalaker, T. O., Larsen, J. O., Dwyer, M. G., Aarsland, D., Beyer, M. K., Alves, G. W., Brønnick, K., Tysnes, O., & Zivadinov, R. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.020 · Cited by 74
Self-citation
Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 in Alzheimer's Disease
Duron, E., Funalot, B., Brunel, N., Coste, J., Quinquis, L., Viollet, C., Belmin, J., Jouanny, P., Pasquier, F., Tréluyer, J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2063 · Cited by 73
Parkinson Disease and Dementia
Ptacek, S. G., & Kramberger, M. G. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716654985 · Cited by 76
Decision making under risk and under ambiguity in Parkinson's disease
Delazer, M., Sinz, H., Zamarian, L., Stockner, H., Seppi, K., Wenning, G. K., Benke, T., & Poewe, W. H. (2009) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2009.02.034 · Cited by 72
Self-citation
Psychometric Properties of the Starkstein Apathy Scale in Patients With Early Untreated Parkinson Disease
Pedersen, K. F., Alves, G. W., Larsen, J. P., Tysnes, O., Møller, S. G., & Brønnick, K. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31823038f2 · Cited by 73
Correlation between decreased CSF α-synuclein and Aβ1–42 in Parkinson disease
Buddhala, C., Campbell, M. C., Perlmutter, J. S., & Kotzbauer, P. T. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.043 · Cited by 72
Parkinson’s Disease and Cognitive Impairment
Yang, Y., Tang, B., & Guo, J. (2016) · Parkinson s Disease · doi:10.1155/2016/6734678 · Cited by 79
MDS clinical diagnostic criteria for Parkinson’s disease in China
Li, J., Jin, M., Wang, L., Qin, B., & Wang, K. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8370-2 · Cited by 71
Overview of Neurocognitive Disorders
McDonald, W. M. (2017) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20160030 · Cited by 82
The site of stimulation moderates neuropsychiatric symptoms after subthalamic deep brain stimulation for Parkinson's disease
Mosley, P. E., Smith, D. D., Coyne, T. J., Silburn, P. A., Breakspear, M. J., & Perry, A. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.03.009 · Cited by 72
Re-standardization of the Korean-Instrumental Activities of Daily Living (K-IADL): Clinical Usefulness for Various Neurogenerative Diseases
Chin, J., Park, J., Yang, S.-J., Yeom, J., Ahn, Y., Baek, M. J., Ryu, H. J., Lee, B. H., Han, N. E., Ryu, K. H., et al. (2018) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2018.17.1.11 · Cited by 71
Pacific Northwest Udall Center of Excellence Clinical Consortium: Study Design and Baseline Cohort Characteristics
Cholerton, B., Zabetian, C. P., Quinn, J. F., Chung, K. A., Peterson, A. L., Espay, A. J., Revilla, F. J., Devoto, J. L., Watson, G. S., Hu, S., et al. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130189 · Cited by 73
Nonmotor Symptoms in Nursing Home Residents with Parkinson's Disease: Prevalence and Effect on Quality of Life
Weerkamp, N. J., Tissingh, G., Poels, P. J. E., Zuidema, S. U., Munneke, M., Koopmans, R. T. C. M., & Bloem, B. R. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12458 · Cited by 71
Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromes
Kalaitzakis, M. E., Walls, A. J., Pearce, R. K. B., & Gentleman, S. M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.005 · Cited by 72
Validation of the Modified Fatigue Impact Scale in Parkinson's disease
Schiehser, D. M., Ayers, C. R., Liu, L., Lessig, S. L., Song, D. S., & Filoteo, J. V. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.11.013 · Cited by 71
Structural and physiological neurovascular changes in idiopathic Parkinson’s disease and its clinical phenotypes
Al–Bachari, S., Vidyasagar, R., Emsley, H. C. A., & Parkes, L. M. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16688919 · Cited by 73
Functional cortical source connectivity of resting state electroencephalographic alpha rhythms shows similar abnormalities in patients with mild cognitive impairment due to Alzheimer’s and Parkinson’s diseases
Babiloni, C., Percio, C. D., Lizio, R., Noce, G., Lopez, S., Soricelli, A., Ferri, R., Pascarelli, M. T., Catania, V., Nobili, F. M., et al. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.01.009 · Cited by 78
Parkinson’s progression markers initiative: a milestone-based strategy to monitor Parkinson’s disease progression
Brumm, M. C., Siderowf, A., Simuni, T., Burghardt, E., Choi, S. H., Caspell-Garcia, C., Chahine, L. M., Mollenhauer, B., Foroud, T., Galasko, D., et al. (2023) · Journal of Parkinson’s Disease · doi:10.3233/jpd-223433 · Cited by 70
Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases
Feleke, R., Reynolds, R. H., Smith, A. M., Tilley, B. S., Taliun, S. A. G., Hardy, J., Matthews, P. M., Gentleman, S., Owen, D. R., Johnson, M. R., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02343-x · Cited by 69
Neuroinflammation is linked to dementia risk in Parkinson’s disease
Kouli, A., Spindler, L. R. B., Fryer, T. D., Hong, Y. T., Malpetti, M., Aigbirhio, F. I., White, S. R., Camacho, M., O'Brien, J. T., & Williams‐Gray, C. H. (2023) · Brain · doi:10.1093/brain/awad322 · Cited by 72
Cognitive complaints in Parkinson’s disease: its relationship with objective cognitive decline
Dujardin, K., Duhamel, A., Delliaux, M., Thomas-Antérion, C., Destée, A., & Defebvre, L. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5268-2 · Cited by 70
The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with P arkinson's disease
Sunwoo, M. K., Jeon, S., Ham, J. H., Hong, J. Y., Lee, J. E., Lee, J. ‐., Sohn, Y. H., & Lee, P. H. (2014) · European Journal of Neurology · doi:10.1111/ene.12412 · Cited by 70
A comparison of gray and white matter density in patients with Parkinson's disease dementia and dementia with Lewy bodies using voxel‐based morphometry
Lee, J. E., Park, B., Song, S., Sohn, Y. H., Park, H., & Lee, P. H. (2009) · Movement Disorders · doi:10.1002/mds.22858 · Cited by 73

Authors: Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., Goldman, J., Goetz, C., Korczyn, A., Lees, A., Levy, R., Litvan, I., McKeith, I., Olanow, W., Poewe, W., Quinn, N., Sampaio, C., Tolosa, E., & Dubois, B.
Affiliations: Istanbul University (TR)
Stavanger University Hospital (NO)
King's College London (GB)
Newcastle University (GB)
Inserm (FR)
Juntendo University (JP)
UNSW Sydney (AU)
University of California, Los Angeles (US)
Mayo Clinic (US)
McGill University Research Centre for Studies in Aging (CA)
Rush University Medical Center (US)
Tel Aviv University (IL)
National Hospital for Neurology and Neurosurgery (GB)
University of Louisville (US)
Newcastle upon Tyne Hospital (GB)
Icahn School of Medicine at Mount Sinai (US)
Innsbruck Medical University (AT)
University of Lisbon (PT)
Hospital Clínic de Barcelona (ES)
Corresponding author: Emre, Murat
ORCID: Aarsland, Dag
Brown, Richard
Burn, David J.
Duyckaerts, Charles
Cummings, Jeffrey
Dickson, Dennis W.
Gauthier, Serge
Goldman, Jennifer
Goetz, Christopher
Korczyn, Amos
Lees, Andrew
Litvan, Irene
McKeith, Ian
Poewe, Werner
Quinn, Niall
Tolosa, Eduardo
Dubois, Bruno
Venue: Movement Disorders
Publisher: Wiley
Published: 2007-05-31
Volume: 22
Issue: 12
Pages: 1689-1707
ISSN: 0885-3185 (ISSN-L)
1531-8257
DOI: 10.1002/mds.21507
OpenAlex: W2166609052
Cited by: 3,027
References: 187
Citations by year: 2026: 141 · 2025: 203 · 2024: 192 · 2023: 174 · 2022: 253 · 2021: 215 · 2020: 202 · 2019: 189 · 2018: 173 · 2017: 153 · 2016: 177 · 2015: 151 · 2014: 161 · 2013: 157 · 2012: 137
FWCI: 8.85
Type: journal article
Language: en
Open access: green
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Movement Disorders (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Research Portal (King's College London) (submittedVersion)
Newcastle University ePrints (Newcastle Univesity)
Funders: Medical Research Council (G0400074)
National Institute on Aging (R01AG024040)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords: Parkinson's disease dementia, clinical criteria, Lewy bodies, dementia prevalence, executive dysfunction, memory impairment, hallucinations, apathy, behavioral symptoms
MeSH terms: Dementia, Diagnosis, Differential, Humans, Neuropsychological Tests, Parkinson Disease, Severity of Illness Index, Task Performance and Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical diagnostic criteria for dementia associated with Parkinson’s disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks